Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-19-026269
Filing Date
2019-12-16
Accepted
2019-12-16 16:34:45
Documents
3
Effectiveness Date
2019-12-16

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82019_citiuspharma.htm S-8 106564
2 OPINION OF WYRICK ROBBINS YATES & PONTON LLP fs82019ex5-1_citiuspharma.htm EX-5.1 6390
3 CONSENT OF WOLF & COMPANY, P.C. fs82019ex23-1_citiuspharma.htm EX-23.1 1848
  Complete submission text file 0001213900-19-026269.txt   115999
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-235535 | Film No.: 191287567
SIC: 2834 Pharmaceutical Preparations